PerpEquities

Equity · Healthcare

UnitedHealth Group Incorporated (UNH) perpetual futures

UNH perpetual futures on 13 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade UNHUSDT.

UnitedHealth Group operates as a comprehensive healthcare enterprise with divisions for health benefits, care delivery, technology consulting, and pharmacy services.

$378.27+1.8%NYSE closed
Open in terminal

Price chart

 

Use the left and right arrow keys to inspect points on the chart.

Collecting venue price data...
venue perp mark · BingX (UNH-USDT)
Auto: highest-volume live perp venueOpen in TradingView

Trading data

Perpetual market activity

13/13 live markets
Venues
13
Live markets
13/13
24h volume
$1.1MCoverage: 12/13 marketsExchange-reported volume: $2.4M
Open interest
$7.1MCoverage: 12/13 markets
Best liquidity
$986.7K
HTX
Tightest spread
+1.3 bps
Bitget
Highest volume
$181.9K
Bitget
Settlement mix
USDT · 12/13
Perp/spot vol.
0.00x
Spot volume $425.9M
OI / float
0.00%
Float $342.8B
Spot performance
1D-0.56%
5D-1.36%
1M-6.88%
6M+31.44%
YTD+12.03%
1Y+3.08%

Venue matrix

13 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
BitgetTradeUNH/USDTTrading$378.070.0% APR
0.000% every 8h
+1.3 bps-$181.9K$426KUSDT20x
XT.comTradeUNH/USDTTrading$378.10+135.2% APR
+0.123% every 8h
+5.6 bps$222.3K$165.7K$992.2KUSDT20x
HTXTradeUNH/USDTTrading$378.27-+43.1 bps$986.7K$155.2K-USDT-
LBankTradeUNH/USDTTrading$378.160.0% APR
0.000% every 8h
+4.2 bps$642.7K$150.6K$128.1KUSDT50x
OKXTradeUNH/USDTTrading$378.13+33.8% APR
+0.031% every 8h
+1.3 bps$6.2K$116.3K$178.1KUSDT20x
BinanceTradeUNH/USDTTrading$378.10+2.4% APR
+0.00218% every 8h
+5.6 bps$25.4K$114K$63.5KUSDT-
MEXCTradeUNH/USDTTrading$378.08-15.0% APR
-0.014% every 8h
+5.3 bps$605.8K$101.6K$5MUSDT100x
BitunixTradeUNH/USDTTrading$378.12+3.8% APR
+0.00349% every 8h
+10.3 bps$31.1K$75.4K$31.2KUSDT20x
BybitTradeUNH/USDTTrading$378.880.0% APR
0.000% every 8h
+9.8 bps$9K$46.6K$217.5KUSDT25x
BloFinTradeUNH/USDTTrading$377.92+3.0% APR
+0.00270% every 8h
+5.8 bps$33.8K$23.2K$38.3KUSDT20x
Crypto.com ExchangeTradeUNH/USDTrading$377.56+13.2% APR
+0.00150% every 1h
+7.4 bps$3.1K$2.8K$2.3KUSD50x
Gate.ioTradeUNH/USDTTrading$378.170.0% APR
0.000% every 8h
+8.2 bps-$2.3K$102.8KUSDT25x
BingXTradeUNH-USDTTrading$378.12+32.6% APR
+0.030% every 8h
+8.5 bps$16.5K$1.3M⚠$3.6KUSDT-

Unverified volume: implausibly high against open interest, a typical sign of wash trading. These venues are listed last.

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

Broad liquidity · 9 of 13 venues absorb $10k · Typical cost: +14.2 bps – +53.3 bps

Cheapest execution: LBank · +8.9 bps

Too thin: OKX, Crypto.com Exchange

No fresh book data: Bitget, Gate.io

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

UNH

Tightest spread

UNH

Highest volume

UNH

Funding history

Stored venue snapshots by market

Company data

Company fundamentals

Updated 59m ago
Market cap
$343.8B
Updated 59m ago
Revenue
$450.1B
Trailing 12 months
Revenue growth
0%
Next fiscal year
Profit margin
+3.1%
P/E
24.3
Peer P/E 28.5
Free cash flow
$23.6B
Trailing 12 months
More metrics
Net income
$14.1B
Trailing 12 months
P/S
0.8
Peer P/E
28.5
Similar listed perps
Revenue estimate
$446B
Next fiscal year
Earnings
2026-10-13
Revenue est. $111.3B · Updated 59m ago
Dividend
$2.32
2026-09-14

Fundamental detail

Annual + quarterly
Latest revenue$447.6B
Net margin+2.7%
Free cash flow$16.1B
Net debt$54B
2020$257.1B
2021$287.6B
2022$324.2B
2023$371.6B
2024$400.3B
2025$447.6B
PeriodRevenueGrowthNet incomeFCF
2020$257.1B+6%$15.4B$20.1B
2021$287.6B+12%$17.3B$19.9B
2022$324.2B+13%$20.1B$23.4B
2023$371.6B+15%$22.4B$25.7B
2024$400.3B+8%$14.4B$20.7B
2025$447.6B+12%$12.1B$16.1B
PeriodGross marginOperating marginNet marginROEROA
2020+26.1%+8.7%+6.0%+23.5%+7.8%
2021+24.2%+8.3%+6.0%+24.1%+8.1%
2022+24.6%+8.8%+6.2%+25.9%+8.2%
2023+24.5%+8.7%+6.0%+25.2%+8.2%
2024+22.3%+8.1%+3.6%+15.5%+4.8%
2025+18.5%+4.2%+2.7%+12.8%+3.9%
PeriodCashDebtNet debtCurrent ratio
2020$16.9B$43.5B$26.5B0.74
2021$21.4B$46B$24.6B0.79
2022$23.4B$57.6B$34.3B0.77
2023$25.4B$67.4B$42B0.79
2024$25.3B$76.9B$51.6B0.83
2025$24.4B$78.4B$54B0.79
PeriodMarket capEnterprise valueP/SP/E
2020$331.7B$358.3B1.321.5
2021$473.5B$498.1B1.627.4
2022$495.2B$529.4B1.524.6
2023$500.5B$542.5B1.322.4
2024$469.9B$521.5B1.232.3
2025$300.4B$354.4B0.725.0
Q3 2024$100.8B
Q4 2024$100.8B
Q1 2025$109.6B
Q2 2025$111.6B
Q3 2025$113.2B
Q4 2025$113.2B
Q1 2026$111.7B
Q2 2026$112B
PeriodRevenueGrowthNet incomeFCF
Q3 2024$100.8B+9%$6.1B$13B
Q4 2024$100.8B+7%$5.5B$1.5B
Q1 2025$109.6B+10%$6.3B$4.6B
Q2 2025$111.6B+13%$3.4B$6.3B
Q3 2025$113.2B+12%$2.3B$5.1B
Q4 2025$113.2B+12%$10M$160M
Q1 2026$111.7B+2%$6.3B$8.1B
Q2 2026$112B0%$5.5B$10.3B
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+22.8%+8.6%+6.0%+6.4%+2.0%
Q4 2024+21.1%+7.7%+5.5%+6.0%+1.9%
Q1 2025+21.7%+8.3%+5.7%+6.6%+2.0%
Q2 2025+17.9%+4.6%+3.1%+3.6%+1.1%
Q3 2025+18.2%+3.8%+2.1%+2.5%+0.7%
Q4 2025+16.3%+0.3%0.0%0.0%0.0%
Q1 2026+22.7%+8.0%+5.6%+6.4%+2.0%
Q2 2026+32.7%+7.1%+4.9%+5.6%+1.8%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$32.4B$78B$45.6B0.91
Q4 2024$25.3B$76.9B$51.6B0.83
Q1 2025$30.7B$81.3B$50.6B0.85
Q2 2025$28.6B$79.2B$50.6B0.85
Q3 2025$27.2B$80.1B$52.9B0.82
Q4 2025$24.4B$78.4B$54B0.79
Q1 2026$28B$77.9B$49.9B0.80
Q2 2026$28.6B$73.3B$44.7B0.78
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$539.7B$585.3B5.422.3
Q4 2024$468.9B$520.5B4.721.1
Q1 2025$480.8B$531.4B4.418.9
Q2 2025$283.9B$334.5B2.520.7
Q3 2025$313.5B$366.5B2.833.3
Q4 2025$300.4B$354.4B2.77,502.5
Q1 2026$246.2B$296.2B2.29.8
Q2 2026$376.6B$421.3B3.417.2

Refreshed 59m ago

Charts: revenue, profit, cash flow & valuation
Revenue$112BQ2 2026
$28.3B$56.6B$84.9B$113.2BQ3 2023: $92.4BQ4 2023: $94.4BQ1 2024: $99.8BQ2 2024: $98.9BQ3 2024: $100.8BQ4 2024: $100.8BQ1 2025: $109.6BQ2 2025: $111.6BQ3 2025: $113.2BQ4 2025: $113.2BQ1 2026: $111.7BQ2 2026: $112BQ3 2023Q2 2026
Net income$5.5BQ2 2026
$516.3M$2.4B$4.4B$6.3BQ3 2023: $5.8BQ4 2023: $5.5BQ1 2024: -$1.4BQ2 2024: $4.2BQ3 2024: $6.1BQ4 2024: $5.5BQ1 2025: $6.3BQ2 2025: $3.4BQ3 2025: $2.3BQ4 2025: $10MQ1 2026: $6.3BQ2 2026: $5.5BQ3 2023Q2 2026
EBITDA$9BQ2 2026
$2.5B$5.1B$7.6B$10.2BQ3 2023: $9.5BQ4 2023: $8.7BQ1 2024: $1.8BQ2 2024: $7.7BQ3 2024: $9.7BQ4 2024: $8.8BQ1 2025: $10.2BQ2 2025: $6.2BQ3 2025: $5.3BQ4 2025: $1.4BQ1 2026: $10.1BQ2 2026: $9BQ3 2023Q2 2026
Free cash flow$10.3BQ2 2026
-$1.4B$3.4B$8.2B$13BQ3 2023: $6.1BQ4 2023: -$6.2BQ1 2024: $401MQ2 2024: $5.9BQ3 2024: $13BQ4 2024: $1.5BQ1 2025: $4.6BQ2 2025: $6.3BQ3 2025: $5.1BQ4 2025: $160MQ1 2026: $8.1BQ2 2026: $10.3BQ3 2023Q2 2026
EPS$6.05Q2 2026
$0.58$2.68$4.79$6.9Q3 2023: $6.24Q4 2023: $5.83Q1 2024: -$1.53Q2 2024: $4.54Q3 2024: $6.51Q4 2024: $5.98Q1 2025: $6.85Q2 2025: $3.74Q3 2025: $2.59Q4 2025: $0.01Q1 2026: $6.9Q2 2026: $6.05Q3 2023Q2 2026
Cash / Debt$28.6BQ2 2026
$20.3B$40.6B$61B$81.3BQ3 2023 · Cash: $38.9BQ3 2023 · Debt: $63.4BQ4 2023 · Cash: $25.4BQ4 2023 · Debt: $67.4BQ1 2024 · Cash: $28.4BQ1 2024 · Debt: $73.6BQ2 2024 · Cash: $26.3BQ2 2024 · Debt: $75.1BQ3 2024 · Cash: $32.4BQ3 2024 · Debt: $78BQ4 2024 · Cash: $25.3BQ4 2024 · Debt: $76.9BQ1 2025 · Cash: $30.7BQ1 2025 · Debt: $81.3BQ2 2025 · Cash: $28.6BQ2 2025 · Debt: $79.2BQ3 2025 · Cash: $27.2BQ3 2025 · Debt: $80.1BQ4 2025 · Cash: $24.4BQ4 2025 · Debt: $78.4BQ1 2026 · Cash: $28BQ1 2026 · Debt: $77.9BQ2 2026 · Cash: $28.6BQ2 2026 · Debt: $73.3BQ3 2023Q2 2026
CashDebt
Profitability+32.7%Q2 2026
+7.1%+15.7%+24.2%+32.7%Q3 2023 · Gross margin: +25.3%Q4 2023 · Gross margin: +23.3%Q1 2024 · Gross margin: +23.1%Q2 2024 · Gross margin: +22.3%Q3 2024 · Gross margin: +22.8%Q4 2024 · Gross margin: +21.1%Q1 2025 · Gross margin: +21.7%Q2 2025 · Gross margin: +17.9%Q3 2025 · Gross margin: +18.2%Q4 2025 · Gross margin: +16.3%Q1 2026 · Gross margin: +22.7%Q2 2026 · Gross margin: +32.7%Q3 2023 · Operating margin: +9.2%Q4 2023 · Operating margin: +8.1%Q1 2024 · Operating margin: +7.9%Q2 2024 · Operating margin: +8.0%Q3 2024 · Operating margin: +8.6%Q4 2024 · Operating margin: +7.7%Q1 2025 · Operating margin: +8.3%Q2 2025 · Operating margin: +4.6%Q3 2025 · Operating margin: +3.8%Q4 2025 · Operating margin: +0.3%Q1 2026 · Operating margin: +8.0%Q2 2026 · Operating margin: +7.1%Q3 2023 · Net margin: +6.3%Q4 2023 · Net margin: +5.8%Q1 2024 · Net margin: -1.4%Q2 2024 · Net margin: +4.3%Q3 2024 · Net margin: +6.0%Q4 2024 · Net margin: +5.5%Q1 2025 · Net margin: +5.7%Q2 2025 · Net margin: +3.1%Q3 2025 · Net margin: +2.1%Q4 2025 · Net margin: 0.0%Q1 2026 · Net margin: +5.6%Q2 2026 · Net margin: +4.9%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth+0.4%Q2 2026
+3.2%+6.5%+9.7%+12.9%Q2 2024: +6.4%Q3 2024: +9.2%Q4 2024: +6.8%Q1 2025: +9.8%Q2 2025: +12.9%Q3 2025: +12.2%Q4 2025: +12.3%Q1 2026: +2.0%Q2 2026: +0.4%Q3 2023Q2 2026
Shares outstanding906MQ2 2026
234M468M702M936MQ3 2023: 936MQ4 2023: 935MQ1 2024: 922MQ2 2024: 928MQ3 2024: 930MQ4 2024: 927MQ1 2025: 918MQ2 2025: 910MQ3 2025: 912MQ4 2025: 910MQ1 2026: 910MQ2 2026: 906MQ3 2023Q2 2026
Valuation17.2Q2 2026
1,815.63,711.25,606.97,502.5Q3 2023 · P/E: 20.0Q4 2023 · P/E: 22.9Q1 2024 · P/E: -80.0Q2 2024 · P/E: 27.0Q3 2024 · P/E: 22.3Q4 2024 · P/E: 21.1Q1 2025 · P/E: 18.9Q2 2025 · P/E: 20.7Q3 2025 · P/E: 33.3Q4 2025 · P/E: 7,502.5Q1 2026 · P/E: 9.8Q2 2026 · P/E: 17.2Q3 2023 · P/S: 5.1Q4 2023 · P/S: 5.3Q1 2024 · P/S: 4.5Q2 2024 · P/S: 4.6Q3 2024 · P/S: 5.4Q4 2024 · P/S: 4.7Q1 2025 · P/S: 4.4Q2 2025 · P/S: 2.5Q3 2025 · P/S: 2.8Q4 2025 · P/S: 2.7Q1 2026 · P/S: 2.2Q2 2026 · P/S: 3.4Q3 2023Q2 2026
P/EP/S
Revenue$447.6B2025
$111.9B$223.8B$335.7B$447.6B2018: $226.2B2019: $242.2B2020: $257.1B2021: $287.6B2022: $324.2B2023: $371.6B2024: $400.3B2025: $447.6B20182025
Net income$12.1B2025
$5.6B$11.2B$16.8B$22.4B2018: $12B2019: $13.8B2020: $15.4B2021: $17.3B2022: $20.1B2023: $22.4B2024: $14.4B2025: $12.1B20182025
EBITDA$23.1B2025
$9.1B$18.2B$27.2B$36.3B2018: $19.8B2019: $22.4B2020: $25.3B2021: $27.1B2022: $31.8B2023: $36.3B2024: $28.1B2025: $23.1B20182025
Free cash flow$16.1B2025
$6.4B$12.8B$19.3B$25.7B2018: $13.7B2019: $16.4B2020: $20.1B2021: $19.9B2022: $23.4B2023: $25.7B2024: $20.7B2025: $16.1B20182025
EPS$13.22025
$5.97$11.9$17.9$23.92018: $12.22019: $14.32020: $162021: $18.12022: $21.22023: $23.92024: $15.52025: $13.220182025
Cash / Debt$24.4B2025
$19.6B$39.2B$58.8B$78.4B2018 · Cash: $10.9B2018 · Debt: $36.6B2019 · Cash: $11B2019 · Debt: $40.7B2020 · Cash: $16.9B2020 · Debt: $43.5B2021 · Cash: $21.4B2021 · Debt: $46B2022 · Cash: $23.4B2022 · Debt: $57.6B2023 · Cash: $25.4B2023 · Debt: $67.4B2024 · Cash: $25.3B2024 · Debt: $76.9B2025 · Cash: $24.4B2025 · Debt: $78.4B20182025
CashDebt
Profitability+18.5%2025
+6.5%+13.0%+19.5%+26.1%2018 · Gross margin: +23.8%2019 · Gross margin: +23.8%2020 · Gross margin: +26.1%2021 · Gross margin: +24.2%2022 · Gross margin: +24.6%2023 · Gross margin: +24.5%2024 · Gross margin: +22.3%2025 · Gross margin: +18.5%2018 · Operating margin: +7.7%2019 · Operating margin: +8.1%2020 · Operating margin: +8.7%2021 · Operating margin: +8.3%2022 · Operating margin: +8.8%2023 · Operating margin: +8.7%2024 · Operating margin: +8.1%2025 · Operating margin: +4.2%2018 · Net margin: +5.3%2019 · Net margin: +5.7%2020 · Net margin: +6.0%2021 · Net margin: +6.0%2022 · Net margin: +6.2%2023 · Net margin: +6.0%2024 · Net margin: +3.6%2025 · Net margin: +2.7%20182025
Gross marginOperating marginNet margin
Revenue growth+11.8%2025
+3.7%+7.3%+11.0%+14.6%2019: +7.0%2020: +6.2%2021: +11.8%2022: +12.7%2023: +14.6%2024: +7.7%2025: +11.8%20182025
Shares outstanding910M2025
245.8M491.5M737.3M983M2018: 983M2019: 966M2020: 961M2021: 956M2022: 950M2023: 938M2024: 929M2025: 910M20182025
Valuation25.02025
8.116.224.332.32018 · P/E: 20.02019 · P/E: 20.22020 · P/E: 21.52021 · P/E: 27.42022 · P/E: 24.62023 · P/E: 22.42024 · P/E: 32.32025 · P/E: 25.02018 · P/S: 1.12019 · P/S: 1.22020 · P/S: 1.32021 · P/S: 1.62022 · P/S: 1.52023 · P/S: 1.32024 · P/S: 1.22025 · P/S: 0.720182025
P/EP/S

Next catalyst

Catalysts

Earnings
2026-10-13
Revenue est. $111.3B · Updated 59m ago
Dividend
$2.32
2026-09-14

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 202619.95$446B0%18
FY 202722.63$459.2B+3%18
FY 202826.36$486.4B+9%13
FY 202931.25$514B+15%10
FY 203035.43$556B+24%5
Q1 20278.14$112B0%8

Company events

6
2026-10-13Earnings · Before market openActual - / Estimate 4.12-
2026-09-14Dividend$2.32-
2026-07-16EarningsActual 6.38 / Estimate 4.94Beat
2026-06-15Dividend$2.32-
2026-04-21EarningsActual 7.23 / Estimate 6.46Beat
2026-03-09Dividend$2.21-

Peer comparison

Similar listed perps

FMP company data

Company intelligence

Updated: Oct 5, 2026, 08:46 PM UTC

Company profile

Sector
Healthcare
Industry
Medical - Healthcare Plans
Chief executive
Stephen J. Hemsley
Employees
390,000
IPO date
Oct 17, 1984
Country
US
Exchange
New York Stock Exchange
Website
Altman Z-scorei3.03
Piotroski scorei8/9
FMP ratingiB+
Owner earningsi$10.27B$11.33 per share
ESG risk ratingiBIndustry rank: 8 out of 15

Rating factors

Return on equityi
4
Return on assetsi
5
Debt to equityi
1
Price to earningsi
2
Price to booki
2
Market cap history
$336.94B-11.4%Jul 26 – Oct 26
$336.94B$362.85B$388.75BHigh: $388.75B · 2026-07-13Latest: $336.94B · 2026-10-02Jul 26Aug 26Sep 26Oct 26
Latest: $336.94B · 2026-10-02High: $388.75B · 2026-07-13Low: $336.94B · 2026-10-02
Largest fund holders
FundWeightShares held
VCPA.S0.73%34.9M
VTI0.48%28.9M
VOO0.53%24.1M
FXAIX0.58%13M
IVV0.51%12M
1657.T0.39%12M
XAW.TO0.3%12M
SCHD3.88%11.5M
1557.T0.5%11.1M
SPY0.5%11M
VSCA.S0.3%9.1M
VTV1.29%8.7M

Analyst track record

How the analysts covering UNH have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings157521
Analysts2732
Buy / hold / sell131 / 24 / 2461 / 54 / 6
Upgrades / downgrades / initiations5 / 2 / 211 / 17 / 6
Price targets hit / missed26 / 120 (18%)90 / 386 (19%)
Avg. return after a rating (TipRanks)-10.1%-21.3%
Best / worst call+40.5% / -31.0%+84.4% / -48.9%

After buy calls on this stock: median 21-day move +1.1% vs S&P 500 -0.8% (n = 456)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Scott FidelGoldman Sachs89% hit rate on this stock · 9 targets measuredBuytarget $490Jul 16, 2026
  2. Ann HynesMizuho Securities71% hit rate on this stock · 17 targets measuredBuytarget $493Jul 21, 2026
  3. Erin WrightMorgan Stanley70% hit rate on this stock · 20 targets measuredBuytarget $529Jul 17, 2026

Latest ratings

DateAnalystCallTarget
Oct 5, 2026Lance WilkesBernsteinBuyMaintained$512
Oct 5, 2026Lance WilkesBernsteinBuyMaintained$512
Sep 15, 2026Stephen BaxterWells FargoBuyMaintained$526
Sep 14, 2026Elizabeth Anderson CFAEvercore ISIBuyMaintained$480
Sep 14, 2026A.J. RiceUBSBuyMaintained$490
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$300$350$400$450Nov 25 · Buy 17 · Hold 4 · Sell 2Nov 25Dec 25 · Buy 17 · Hold 3 · Sell 2Jan 26 · Buy 18 · Hold 3 · Sell 2Jan 26Feb 26 · Buy 19 · Hold 3 · Sell 1Mar 26 · Buy 19 · Hold 3 · Sell 1Mar 26Apr 26 · Buy 21 · Hold 4 · Sell 1May 26 · Buy 21 · Hold 4 · Sell 1May 26Jun 26 · Buy 22 · Hold 3 · Sell 1Jul 26 · Buy 21 · Hold 4 · Sell 0Jul 26Aug 26 · Buy 19 · Hold 5 · Sell 0Sep 26 · Buy 19 · Hold 5 · Sell 0Sep 26Oct 26 · Buy 19 · Hold 5 · Sell 0Nov 25 · avg. target $383Dec 25 · avg. target $383Jan 26 · avg. target $357Feb 26 · avg. target $363Mar 26 · avg. target $363Apr 26 · avg. target $385May 26 · avg. target $394Jun 26 · avg. target $406Jul 26 · avg. target $459Aug 26 · avg. target $467Sep 26 · avg. target $471Oct 26 · avg. target $471Nov 25 · month-end close $330Dec 25 · month-end close $330Jan 26 · month-end close $287Feb 26 · month-end close $293Mar 26 · month-end close $271Apr 26 · month-end close $370May 26 · month-end close $380Jun 26 · month-end close $416Jul 26 · month-end close $414Aug 26 · month-end close $389Sep 26 · month-end close $367Oct 26 · month-end close $372

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data via FMP · computed Oct 5, 2026 · 157 ratings

Frequently asked questions

Where can I trade UNH perpetual futures?

UnitedHealth Group Incorporated (UNH) perpetual futures trade on 13 crypto venues, including BingX, Bitget, XT.com. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade UNH around the clock?

Yes. Unlike the underlying stock, UNH perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on UNH perpetuals?

Right now the UNH perp funding rate is +2.7% annualized (venue median), ranging from -15.0% to +135.2% across 13 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the UNH perp price compare to the UnitedHealth Group Incorporated stock?

The venue-median UNH perp mark is $378.1 versus a reference stock price of $378.3, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a UNH perpetual future?

A UNH perpetual is a derivative that tracks the price of UnitedHealth Group Incorporated with no expiry date. It lets you take long or short exposure to UnitedHealth Group Incorporated on crypto venues, around the clock.

What is UNHUSDT perpetual?

UNHUSDT is the symbol most crypto exchanges use for the UnitedHealth Group Incorporated perpetual settled in USDT (Tether). It tracks the UNH share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

UNH perpetuals · perpequities.comUNH perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/unh-perp"><img src="https://perpequities.com/badge/unh-perp.svg" width="240" height="64" alt="UNH perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of UNH perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for UNH — one email every Sunday.

Watchlist and alerts

Price and funding alerts for UNH, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X